about
Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice.Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinomaCould metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Targeting the insulin-like growth factor pathway in hepatocellular carcinomaWnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic miceDifferential prioritization between relevance and redundancy in correlation-based feature selection techniques for multiclass gene expression data.Identification of bioactive molecules by adipogenesis profiling of organic compounds.Microarray data analysis of mouse neoplasia.Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.Targeting insulin-like growth factor axis in hepatocellular carcinoma.IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF SignalTranscript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesisInsulin resistance and chronic liver disease.Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C.Chemopreventive potential of green tea catechins in hepatocellular carcinoma.cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis.Receptor binding characteristics and cytotoxicity of insulin-methotrexate.Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis.Study on the possibility of insulin as a carrier of IUdR for hepatocellular carcinoma-targeted therapyExpression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinomaEfficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study.Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathwayTransgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only.Biology of SNU cell lines.Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring.Branched-chain amino acids as pharmacological nutrients in chronic liver disease.Hepatocellular carcinoma: the point of view of the hepatitis B virus.Hepatocellular carcinoma and vitamin D: a review.Use of HOMA-IR in hepatitis C.An Overview of Biomarkers and Molecular Signatures in HCC.Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis.Translational control plays a prominent role in the hepatocytic differentiation of HepaRG liver progenitor cells.HIF-2α attenuates lymphangiogenesis by up-regulating IGFBP1 in hepatocellular carcinoma.Occupational exposure to urban pollutants and plasma insulin-like growth factor 1 (IGF-1).A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinomaTargeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice.Inhibition of IGF receptor signaling and hepatoma cell growth by an antibody to ligand oligopeptide of receptor.Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells.Serine 204 phosphorylation and O-β-GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma.
P2860
Q24813432-1939583E-D7F6-4588-88EB-C3A158A24FDDQ26766068-3F6636D8-28A3-4050-8632-29703D0A350BQ26824893-C79B5929-B03C-4DAB-B3FE-3B01D032B543Q27006846-BD269531-0181-4F66-AD8C-21D99CADA6C9Q28267847-9DCD482E-BAD8-498C-B863-A8D52AF476BBQ30478009-B57FA670-9FEC-4CCA-A9EE-857DAFE4DDBAQ30877450-5871A9C2-9AF5-45C4-A492-86001BA8C815Q30986312-39111002-5DA3-4E1E-A09B-E53BABE9C5ECQ33248446-60A2A024-C8A1-47C5-AE3E-F93D0C5D7805Q33951057-BB3C461F-A1DF-4025-89DB-15A216724E44Q34647501-8B32D64F-86C5-4495-B656-A0104046994BQ34950738-B36AFB1D-51B5-4BF1-994C-C7DC813F80CDQ35039264-7F8B73A3-F37B-4694-A262-2BF8E10C053AQ35073012-BA1CAB4F-CA50-4D2E-BCAF-ECF7BFDFB58FQ35270206-2CE89E67-6462-4210-B22C-FDC146A78E9CQ35381561-3D487BEB-ED34-4BFC-ACF4-E3E231D51D14Q35791300-B8B2B7A5-1F31-4A4F-AA35-5E53B4BFCFF7Q36076603-64CDC102-7365-438B-91FD-89481484E51CQ36178311-127CF008-0202-4A5E-A83F-A7701F5DF28BQ36178878-A17B6A56-B966-438D-B695-8554702324FCQ36190335-339DFE12-8A6A-4724-AB71-E3BFAA573A3BQ36611050-B19BE886-FC8E-4467-80CE-5806229DE807Q36818088-34DAC55A-A37C-415D-983B-B92ED9E18CCAQ36972045-4A72B22D-4BE2-466C-B287-79263A8F4C27Q37447033-5A35BB49-F75E-4F4C-BF34-F4E196D63A5AQ37534945-5EFE2631-DF21-417A-8187-FA1E2062DE83Q37874555-A159B8FE-1A30-4CE8-88D3-D838DAAE515DQ37888329-25E01A62-7EA5-45F8-BEE3-D0DED9E5AE4EQ37924314-06036726-48FE-46E1-A873-2ECAE085DF01Q37931383-626A3129-4040-460C-801F-FB74015E9D52Q38166571-715C9E18-151E-45F0-A950-7E69C8315CCAQ38293829-38DE9A6E-3A88-4CFD-93A1-331649360D37Q38610703-546F11EB-C1D8-4B09-A268-7D8D8C5282EEQ38901614-B2811A46-BD47-43CA-8AD2-DA5608CC3E0EQ39687675-20D0E399-40EE-48C3-80FC-C49249E59BFAQ39740934-F898E5E8-4A58-4858-BBB5-AC3A0B0497AFQ39904702-AE71FC4F-8435-4A69-99AD-D960188C748FQ39998569-68333A9C-B0C2-44CC-951E-EFD0CF12053CQ40697307-56CE37E3-3406-47BA-95C7-9F4E07CBE69CQ41818701-0A1257C6-B1C2-4A5F-97F1-743F5FE9F682
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The IGF axis and hepatocarcinogenesis.
@ast
The IGF axis and hepatocarcinogenesis.
@en
type
label
The IGF axis and hepatocarcinogenesis.
@ast
The IGF axis and hepatocarcinogenesis.
@en
prefLabel
The IGF axis and hepatocarcinogenesis.
@ast
The IGF axis and hepatocarcinogenesis.
@en
P2093
P2860
P356
P1476
The IGF axis and hepatocarcinogenesis.
@en
P2093
F Dombrowski
G Ramadori
J G Scharf
P2860
P304
P356
10.1136/MP.54.3.138
P407
P577
2001-06-01T00:00:00Z